The Regents of the University of Colorado; a body corporate
发明人:
LIU, Xuedong,ZHANG, Gan,CHAN, Daniel, Chuen-Fong,PISCOPIO, Anthony, D.
申请号:
EP15792349
公开号:
EP3142652A4
申请日:
2015.05.14
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present invention relates to novel hydroxamic acids which are specific histone deacetylase (HDAC) inhibitors and/or TTK/Mps1 kinase inhibitors, including pharmaceutically acceptable salts thereof, which are useful for modulating HDAC and/or TTK/Mps1 kinase activity, pharmaceutical compositions comprising these compounds, and processes for their preparation.